Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapinarof vs Betamethasone in Plaque Psoriasis
NCT07635043Phase 4Not yet recruiting
- Sponsor
- Pakistan Institute of Medical Sciences
- Start
- Aug 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 4 trial of tapinarof in plaque psoriasis, sponsored by Pakistan Institute of Medical Sciences. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07635043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635043.